Theriva Biologics Q4 EPS $(0.12) Beats $(0.50) Estimate
Benzinga Newsdesk 7 months ago
EarningsEarnings BeatsNews
Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.50) by 76.2 percent. This is a 92.52 percent increase over losses of $(1.59) per share from
Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.50) by 76.2 percent. This is a 92.52 percent increase over losses of $(1.59) per share from the same period last year.